株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

eクリニカルソリューションの世界市場予測 2022年:CDMS、EDC、CTMS、eCOA、分析、RTSM、eTMF、他

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022

発行 MarketsandMarkets 商品コード 249136
出版日 ページ情報 英文 167 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.48円で換算しております。
Back to Top
eクリニカルソリューションの世界市場予測 2022年:CDMS、EDC、CTMS、eCOA、分析、RTSM、eTMF、他 eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022
出版日: 2017年04月19日 ページ情報: 英文 167 Pages
概要

世界のeクリニカルソリューション市場は、2017年〜2022年に12.4%のCAGR (複合年間成長率) で成長し、2022年には76億1000万米ドルの規模に達すると予測されています。市場成長の主な要因として、データ標準化の必要性や、製薬企業やバイオテクノロジー企業での研究開発 (R&D) 投資の拡大、新興国市場での治験活動の活発化などが挙げられます。他方、熟練した専門家の不足や、患者のプライバシー保護への不安感が、市場成長の妨げともなっています。

当レポートは、世界のeクリニカルソリューション市場について調査し、製品、提供形態、治験段階、およびエンドユーザー別による市場の分析、4つの主要地域における市場分析、および主要企業の市場シェア、戦略、製品、流通ネットワーク、製造能力の評価などについて、まとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 主な市場促進因子
      • 治験の運用コスト上昇と規制強化
      • 治験向けソフトウェア・ソリューションの新規導入
      • 治験支援のための政府からの融資・補助金の増額
      • データ標準化の推進のためのeクリニカルソリューションの普及
      • 製薬企業・バイオ医薬品企業の研究開発 (R&D) 投資拡大と、創薬パイプライン関連のIT支出額
      • eクリニカルソリューションの顧客ベースの拡大
    • 主な市場阻害因子
      • eクリニカルソリューションの導入コストの高さ
      • eクリニカルソリューションを運用できる熟練した専門家の不足
      • eクリニカルソリューションの利点に関する、研究者の認識の低さ
    • 主な成長機会
      • アジアの新興国での臨床研究活動の活発化
      • 治験プロセスの外注化:企業内研究部門からCROへ
      • 治験の件数増加 (特に新興国)
      • 手動でのデータ解釈から、治験中でのリアルタイム・データ解析への移行
    • 市場の主な課題
      • 発展途上国でのeクリニカルソリューションの利用制限
      • ソフトウェアの信頼性
      • 患者のプライバシー

第6章 eクリニカルソリューション市場:製品別

  • イントロダクション
  • 電子データ収集 (EDC)・臨床データ管理システム (CDMS)
  • 治験管理システム (CTMS)
  • 臨床分析プラットフォーム
  • ランダム化・治験用品管理 (RTSM)
  • 臨床データ統合プラットフォーム
  • 電子臨床転帰評価 (eCOA) ソリューション
  • 安全性ソリューション
  • 電子治験マスターファイル (eTMF) システム
  • 規制情報管理ソリューション
  • その他のeクリニカルソリューション

第7章 eクリニカルソリューション市場:デリバリー形態別

  • イントロダクション
  • Webホステッド (オンデマンド) ソリューション
  • ライセンス式・企業向け (オンプレミス) ソリューション
  • クラウド型 (SaaS) ソリューション

第8章 eクリニカルソリューション市場:治験段階別

  • イントロダクション
  • 第I相
  • 第II相
  • 第III相
  • 第IV相

第9章 eクリニカルソリューション市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオ医薬品企業
  • 医薬品開発業務受託機関 (CRO)
  • コンサルティングサービス企業
  • 医療機器メーカー
  • 病院
  • 教育・研究機関

第10章 eクリニカルソリューション市場:地域別

  • イントロダクション
  • 北米 (米国、カナダ)
  • 欧州
  • アジア太平洋地域
  • その他

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 協定、事業提携、事業協力
    • 製品導入
    • 製品発売・改良
    • 企業合併・買収 (M&A)
    • 事業拡張
    • その他の戦略

第12章 企業プロファイル

  • イントロダクション
  • ORACLE CORPORATION
  • MEDIDATA SOLUTIONS, INC.
  • PAREXEL INTERNATIONAL CORPORATION
  • BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN)
  • DATATRAK INTERNATIONAL, INC.
  • CRF HEALTH
  • ERT CLINICAL
  • MERGE HEALTHCARE INCORPORATED
  • OMNICOMM SYSTEMS, INC.
  • MAXISIT INC.
  • BIO-OPTRONICS, INC.
  • ECLINICAL SOLUTIONS, LLC.

第13章 付録

目次
Product Code: HIT 2208

"eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (On-Demand, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2022"

The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. However, a dearth of skilled research professionals and concerns over patient data privacy are hampering the adoption of these solutions.

On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period.

Geographically, North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. The large market share of North America is attributed to the significant number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in the number of partnerships for new drug development, high prevalence of lifestyle diseases, and an increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting trials are negatively affecting the growth of the market in this region.

Although developed regions such as North America and Europe held large shares in the eClinical solutions market in 2016, it is the Asia-Pacific region that is poised to achieve the highest CAGR in the next five years. Factors such as the increasing outsourcing of clinical trial studies by large pharma and biopharma companies to Asia-Pacific countries, the presence of large patient population, and the low operating cost of conducting clinical trials are propelling the growth of the eClinical solutions market in this region.

The eClinical solutions market is highly competitive, with a large number of global and local players. Oracle Corporation (U.S.) Medidata Solutions, Inc. (U.S.), and PAREXEL International Corporation (U.S.) were the top three players in the eClinical solutions market in 2016. Partnerships, agreements, and collaborations; product launches, enhancements, and deployments; mergers and acquisitions; and geographic expansions are the major strategies adopted by most players to achieve growth in the eClinical solutions market.

Research Coverage:

The report covers software solutions used across all phases in the clinical trial process. It aims at estimating the market size and future growth potential of this market across different segments such as product type, delivery mode, clinical trial phase, end user, and regions. The report also includes an in-depth competitive analysis of the key players with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

This report focuses on various levels of analysis-market share analysis of the top players and company profiles, which discuss basic views on the competitive landscape; emerging and high-growth segments of the eClinical solutions market; and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help them garner greater market shares. Companies purchasing the report could use any one of the combination of the strategies mentioned below, namely, market penetration, product development/innovation, market development, market diversification, and competitive assessment to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on eClinical solutions offered by the top 10 players in the market. The report analyzes the eClinical solutions market, by product, delivery mode, clinical trial phase, and end users across four geographies.
  • Product Development/Innovation: Detailed insights on current technologies, research and development activities, and product launches in the eClinical solutions market.
  • Market Development: Comprehensive information of lucrative emerging markets. The report analyzes the markets for various eClinical solutions across four geographies (North America, Europe, Asia-Pacific, and the Rest of the World).
  • Competitive Assessment: Assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the eClinical solutions market.

TABLE OF CONTENTS

1 INTRODUCTION 15

  • 1.1 OBJECTIVES OF THE STUDY 15
  • 1.2 MARKET DEFINITION 15
  • 1.3 MARKET SCOPE 16
    • 1.3.1 MARKETS COVERED 16
    • 1.3.2 GEOGRAPHIC SCOPE 16
    • 1.3.3 YEARS CONSIDERED FOR THE STUDY 17
  • 1.4 CURRENCY 17
  • 1.5 LIMITATIONS 17
  • 1.6 MAJOR MARKET STAKEHOLDERS 18

2 RESEARCH METHODOLOGY 19

  • 2.1 RESEARCH DATA 19
    • 2.1.1 SECONDARY DATA 20
      • 2.1.1.1 Key data from secondary sources 20
    • 2.1.2 PRIMARY DATA 21
      • 2.1.2.1 Breakdown of primaries 21
      • 2.1.2.2 Key data from primary sources 22
      • 2.1.2.3 Key industry insights 23
  • 2.2 MARKET SIZE ESTIMATION 23
      • 2.2.1.1 Bottom-up approach 25
      • 2.2.1.2 Top-down approach 26
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
  • 2.4 RESEARCH ASSUMPTIONS 28

3 EXECUTIVE SUMMARY 29

4 PREMIUM INSIGHTS 34

  • 4.1 ECLINICAL SOLUTIONS: MARKET OVERVIEW 34
  • 4.2 ECLINICAL SOLUTIONS MARKET, BY PRODUCT, 2015 VS. 2017 VS. 2022 (USD MILLION) 35
  • 4.3 REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE (2016) 36
  • 4.4 ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2017 VS. 2022) 37
  • 4.5 REGIONAL ANALYSIS: ECLINICAL SOLUTIONS MARKET, BY END USER (2017-2022) 37

5 MARKET OVERVIEW 38

  • 5.1 INTRODUCTION 38
  • 5.2 MARKET DYNAMICS 38

    • 5.2.1 MAJOR MARKET DRIVERS 39
      • 5.2.1.1 Increasing operational costs and regulatory requirements associated with clinical research studies 39
      • 5.2.1.2 Growing adoption of novel software solutions in clinical research 39
      • 5.2.1.3 Rising government funding & grants to support clinical trials 40
      • 5.2.1.4 Growing adoption of eClinical solutions for improved data standardization 41
      • 5.2.1.5 Increasing R&D expenditure by pharma-biotech companies with augmented IT expenditure allocations for drug development pipeline 41
      • 5.2.1.6 Growing customer base for eClinical solutions 42
    • 5.2.2 MAJOR MARKET RESTRAINTS 43
      • 5.2.2.1 High implementation costs associated with eClinical solutions 43
      • 5.2.2.2 Dearth of skilled professionals for operating eClinical solutions 43
      • 5.2.2.3 Limited awareness among researchers related to advantages of eClinical solutions 43
    • 5.2.3 KEY GROWTH OPPORTUNITIES 43
      • 5.2.3.1 Increasing clinical research activities in emerging Asian countries 43
      • 5.2.3.2 Increased outsourcing of clinical trial processes by industrial researchers to CROs 44
      • 5.2.3.3 Rising number of clinical trials, especially across emerging countries 44
      • 5.2.3.4 Shift from manual data interpretation to real-time data analysis during clinical studies 44
    • 5.2.4 MAJOR MARKET CHALLENGES 45
      • 5.2.4.1 Limited adoption of eClinical solutions in developing nations 45
      • 5.2.4.2 Software reliability 45
      • 5.2.4.3 Patient privacy 45

6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT 46

  • 6.1 INTRODUCTION 47
  • 6.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 48
  • 6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS 50
  • 6.4 CLINICAL ANALYTICS PLATFORMS 52
  • 6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 54
  • 6.6 CLINICAL DATA INTEGRATION PLATFORMS 56
  • 6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 57
  • 6.8 SAFETY SOLUTIONS 59
  • 6.9 ELECTRONIC TRIAL MASTER FILE SYSTEMS 60
  • 6.10 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 61
  • 6.11 OTHER ECLINICAL SOLUTIONS 62

7 ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 63

  • 7.1 INTRODUCTION 64
  • 7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 65
  • 7.3 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS 66
  • 7.4 CLOUD-BASED (SAAS) SOLUTIONS 67

8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 69

  • 8.1 INTRODUCTION 70
  • 8.2 PHASE I CLINICAL TRIALS 71
  • 8.3 PHASE II CLINICAL TRIALS 72
  • 8.4 PHASE III CLINICAL TRIALS 73
  • 8.5 PHASE IV CLINICAL TRIALS 75

9 ECLINICAL SOLUTIONS MARKET, BY END USER 76

  • 9.1 INTRODUCTION 77
  • 9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 78
  • 9.3 CONTRACT RESEARCH ORGANIZATIONS 79
  • 9.4 CONSULTING SERVICE COMPANIES 81
  • 9.5 MEDICAL DEVICE MANUFACTURERS 82
  • 9.6 HOSPITALS 83
  • 9.7 ACADEMIC RESEARCH INSTITUTES 84

10 ECLINICAL SOLUTIONS MARKET, BY REGION 85

  • 10.1 INTRODUCTION 86
  • 10.2 NORTH AMERICA 87
    • 10.2.1 U.S. 91
    • 10.2.2 CANADA 93
  • 10.3 EUROPE 95
  • 10.4 ASIA-PACIFIC 102
  • 10.5 REST OF THE WORLD 106

11 COMPETITIVE LANDSCAPE 110

  • 11.1 OVERVIEW 110
  • 11.2 MARKET SHARE ANALYSIS 110
  • 11.3 COMPETITIVE SITUATION AND TRENDS 112
    • 11.3.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 112
    • 11.3.2 PRODUCT DEPLOYMENTS 113
    • 11.3.3 PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS 113
    • 11.3.4 MERGERS & ACQUISITIONS 114
    • 11.3.5 EXPANSIONS 115
    • 11.3.6 OTHER STRATEGIES 116

12 COMPANY PROFILES 117

(Business Overview, Products Offered, Recent Developments)*

  • 12.1 INTRODUCTION 117
  • 12.2 ORACLE CORPORATION 118
  • 12.3 MEDIDATA SOLUTIONS, INC. 124
  • 12.4 PAREXEL INTERNATIONAL CORPORATION 130
  • 12.5 BIOCLINICA, INC. (A SUBSIDIARY OF CINVEN) 134
  • 12.6 DATATRAK INTERNATIONAL, INC. 137
  • 12.7 CRF HEALTH 140
  • 12.8 ERT CLINICAL 142
  • 12.9 MERGE HEALTHCARE INCORPORATED 144
  • 12.10 OMNICOMM SYSTEMS, INC. 146
  • 12.11 MAXISIT INC. 151
  • 12.12 BIO-OPTRONICS, INC. 152
  • 12.13 ECLINICAL SOLUTIONS, LLC. 154

Business Overview, Products Offered, Recent Developments might not be captured in case of unlisted companies.

13 APPENDIX 155

  • 13.1 DISCUSSION GUIDE* 155
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 159
  • 13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 161
  • 13.4 AVAILABLE CUSTOMIZATIONS 162
  • 13.5 RELATED REPORTS 163
  • 13.6 AUTHOR DETAILS 164

LIST OF TABLES

  • TABLE 1: U.S.: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED BETWEEN 2011 & 2015 42
  • TABLE 2: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 48
  • TABLE 3: GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 49
  • TABLE 4: NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 50
  • TABLE 5: GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 51
  • TABLE 6: NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 52
  • TABLE 7: GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 53
  • TABLE 8: NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 54
  • TABLE 9: GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 55
  • TABLE 10: NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 56
  • TABLE 11: GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 57
  • TABLE 12: NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 57
  • TABLE 13: GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 58
  • TABLE 14: NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 58
  • TABLE 15: GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 59
  • TABLE 16: NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 59
  • TABLE 17: GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 60
  • TABLE 18: NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 60
  • TABLE 19: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 61
  • TABLE 20: NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015-2022 (USD MILLION) 61
  • TABLE 21: GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 62
  • TABLE 22: NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 62
  • TABLE 23: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015-2022 (USD MILLION) 65
  • TABLE 24: WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 65
  • TABLE 25: LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 66
  • TABLE 26: CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 68
  • TABLE 27: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 70
  • TABLE 28: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION) 71
  • TABLE 29: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION) 72
  • TABLE 30: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION) 73
  • TABLE 31: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION) 73
  • TABLE 32: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION) 74
  • TABLE 33: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION) 74
  • TABLE 34: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY REGION, 2015-2022 (USD MILLION) 75
  • TABLE 35: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS, BY COUNTRY, 2015-2022 (USD MILLION) 75
  • TABLE 36: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 77
  • TABLE 37: ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015-2022 (USD MILLION) 79
  • TABLE 38: KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011-2015) 80
  • TABLE 39: ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION, 2015-2022 (USD MILLION) 80
  • TABLE 40: ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015-2022 (USD MILLION) 81
  • TABLE 41: ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015-2022 (USD MILLION) 82
  • TABLE 42: ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION, 2015-2022 (USD MILLION) 83
  • TABLE 43: ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015-2022 (USD MILLION) 84
  • TABLE 44: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015-2022 (USD MILLION) 87
  • TABLE 45: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015-2022 (USD MILLION) 89
  • TABLE 46: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 89
  • TABLE 47: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION) 90
  • TABLE 48: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 90
  • TABLE 49: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 91
  • TABLE 50: U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 92
  • TABLE 51: U.S.: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 93
  • TABLE 52: CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 94
  • TABLE 53: CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 94
  • TABLE 54: EMA-APPROVED BIOSIMILARS 96
  • TABLE 55: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 100
  • TABLE 56: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION) 100
  • TABLE 57: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 101
  • TABLE 58: EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 101
  • TABLE 59: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 104
  • TABLE 60: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION) 104
  • TABLE 61: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 105
  • TABLE 62: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 105
  • TABLE 63: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015-2022 (USD MILLION) 107
  • TABLE 64: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015-2022 (USD MILLION) 108
  • TABLE 65: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015-2022 (USD MILLION) 108
  • TABLE 66: ROW: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION) 109
  • TABLE 67: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2013-2017) 112
  • TABLE 68: PRODUCT DEPLOYMENTS (2013-2017) 113
  • TABLE 69: PRODUCT LAUNCHES & PRODUCT ENHANCEMENTS (2013-2017) 114
  • TABLE 70: MERGERS & ACQUISITIONS (2013-2017) 114
  • TABLE 71: EXPANSIONS (2013-2017) 115
  • TABLE 72: OTHER STRATEGIES (2013-2017) 116

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN 19
  • FIGURE 2: BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 21
  • FIGURE 3: ECLINICAL SOLUTIONS MARKET: END-USER ANALYSIS APPROACH 24
  • FIGURE 4: ECLINICAL SOLUTIONS MARKET: BOTTOM-UP APPROACH 25
  • FIGURE 5: ECLINICAL SOLUTIONS MARKET: TOP-DOWN APPROACH 26
  • FIGURE 6: ECLINICAL SOLUTIONS MARKET: DATA TRIANGULATION 27
  • FIGURE 7: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2017 VS. 2022 (USD MILLION) 30
  • FIGURE 8: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2017 VS. 2022 (USD MILLION) 31
  • FIGURE 9: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2017 VS. 2022 (USD MILLION) 31
  • FIGURE 10: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2017 VS. 2022 (USD MILLION) 32
  • FIGURE 11: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2016 (USD MILLION) 33
  • FIGURE 12: EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 34
  • FIGURE 13: EDC & CDMS SEGMENT TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2022 35
  • FIGURE 14: WEB-HOSTED DELIVERY MODE DOMINATED THE ECLINICAL SOLUTIONS MARKET ACROSS ALL REGIONAL SEGMENTS IN 2016 36
  • FIGURE 15: PHASE III CLINICAL TRIALS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET DURING THE FORECAST PERIOD 37
  • FIGURE 16: CONTRACT RESEARCH ORGANIZATIONS SEGMENT IN ASIA-PACIFIC IS EXPECTED TO WITNESS THE HIGHEST GROWTH RATE 37
  • FIGURE 17: GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
  • FIGURE 18: EDC AND CDMS SEGMENT DOMINATED THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016 47
  • FIGURE 19: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR EDC AND CDMS SOLUTIONS MARKET IN 2017 49
  • FIGURE 20: ASIA-PACIFIC PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR CTMS MARKET DURING 2017-2022 51
  • FIGURE 21: NORTH AMERICA IS ESTIMATED TO BE THE LARGEST GEOGRAPHIC SEGMENT FOR CLINICAL ANALYTICS PLATFORMS MARKET IN 2017 53
  • FIGURE 22: ASIA-PACIFIC IS PROJECTED TO BE THE FASTEST-GROWING GEOGRAPHIC SEGMENT FOR RTSM SOLUTIONS MARKET TILL 2022 55
  • FIGURE 23: WEB-HOSTED SOLUTIONS TO DOMINATE THE GLOBAL ECLINICAL SOLUTIONS MARKET IN 2016 64
  • FIGURE 24: PHASE III TRIALS TO WITNESS HIGHEST DEMAND GROWTH FOR ECLINICAL SOLUTIONS DURING THE FORECAST PERIOD 70
  • FIGURE 25: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2016) 77
  • FIGURE 26: R&D EXPENDITURE OF TOP 8 PHARMACEUTICAL COMPANIES, 2013 VS. 2015 (USD MILLION) 78
  • FIGURE 27: GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2017 VS. 2022 (USD MILLION) 86
  • FIGURE 28: NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT 88
  • FIGURE 29: EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT 95
  • FIGURE 30: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY (2012) 99
  • FIGURE 31: ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT 102
  • FIGURE 32: ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT 106
  • FIGURE 33: GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2016 110
  • FIGURE 34: GEOGRAPHIC REVENUE MIX OF THE LEADING MARKET PLAYERS (2015)* 117
  • FIGURE 35: ORACLE CORPORATION: COMPANY SNAPSHOT (2016) 118
  • FIGURE 36: MEDIDATA SOLUTIONS, INC.: COMPANY SNAPSHOT (2015) 124
  • FIGURE 37: PAREXEL INTERNATIONAL CORPORATION: COMPANY SNAPSHOT (2016) 130
  • FIGURE 38: DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015) 137
  • FIGURE 39: MERGE HEALTHCARE INCORPORATED: COMPANY SNAPSHOT (2014) 144
  • FIGURE 40: OMNICOMM SYSTEMS, INC.: COMPANY SNAPSHOT (2015) 146
Back to Top